Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tumor Mutation Burden and Cancer Treatment.

Literature DB >> 33331847

Tumor Mutation Burden and Cancer Treatment.

Michael J Fusco¹, Howard Jack West², Christine M Walko¹.

Abstract

Entities: Chemical

Mesh：

Substances：
Biomarkers, Tumor

Year: 2021 PMID： 33331847 DOI： 10.1001/jamaoncol.2020.6371

Source DB: PubMed Journal: JAMA Oncol ISSN： 2374-2437 Impact factor: 31.777

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

1. Association of PD-L1 expression, tumor mutational burden and immunotherapy with venous thrombosis in patients with solid organ malignancies.

Authors: Rajat Thawani; Thomas Kartika; Benjamin Elstrott; Elizabeth Batiuk; Derrick Tao; Sonia Gowda; Lilian Chen; Corinne Lavasseur; Nattapron Tun; Nicholas F Taflin; Joseph Shatzel
Journal: Thromb Res Date: 2022-06-30 Impact factor: 10.407

2. Characterizing the mutational landscape of MM and its precursor MGUS.

Authors: Akanksha Farswan; Anubha Gupta; Lingaraja Jena; Vivek Ruhela; Gurvinder Kaur; Ritu Gupta
Journal: Am J Cancer Res Date: 2022-04-15 Impact factor: 5.942

Review 3. Oncolytic Vaccinia Virus in Lung Cancer Vaccines.

Authors: Cao-Sang Truong; So Young Yoo
Journal: Vaccines (Basel) Date: 2022-02-04

Review 4. Personalised Therapies for Metastatic Triple-Negative Breast Cancer: When Target Is Not Everything.

Authors: Serena Capici; Luca Carlofrancesco Ammoni; Nicole Meli; Viola Cogliati; Francesca Fulvia Pepe; Francesca Piazza; Marina Elena Cazzaniga
Journal: Cancers (Basel) Date: 2022-07-31 Impact factor: 6.575

5. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma.

Authors: Junbo Xiao; Xiaotong Wang; Yajun Liu; Xiaowei Liu; Jun Yi; Jiuye Hu
Journal: Front Immunol Date: 2022-07-11 Impact factor: 8.786

Tumor Mutation Burden and Cancer Treatment.

1. Association of PD-L1 expression, tumor mutational burden and immunotherapy with venous thrombosis in patients with solid organ malignancies.

2. Characterizing the mutational landscape of MM and its precursor MGUS.

Review 3. Oncolytic Vaccinia Virus in Lung Cancer Vaccines.

Review 4. Personalised Therapies for Metastatic Triple-Negative Breast Cancer: When Target Is Not Everything.

5. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma.

6. Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma.

Review 7. Importance of the endometrial immune environment in endometrial cancer and associated therapies.

8. Integrated analysis of senescence-associated genes in pancreatic ductal adenocarcinoma.

9. A comprehensive pan-cancer analysis on the immunological role and prognostic value of TYMP in human cancers.

10. Prognosis and tumor immune microenvironment of patients with gastric cancer by a novel senescence-related signature.